Syd Johnson

11.7k total citations · 2 hit papers
80 papers, 8.8k citations indexed

About

Syd Johnson is a scholar working on Immunology, Radiology, Nuclear Medicine and Imaging and Public Health, Environmental and Occupational Health. According to data from OpenAlex, Syd Johnson has authored 80 papers receiving a total of 8.8k indexed citations (citations by other indexed papers that have themselves been cited), including 31 papers in Immunology, 30 papers in Radiology, Nuclear Medicine and Imaging and 27 papers in Public Health, Environmental and Occupational Health. Recurrent topics in Syd Johnson's work include Monoclonal and Polyclonal Antibodies Research (30 papers), Mosquito-borne diseases and control (24 papers) and Viral Infections and Vectors (19 papers). Syd Johnson is often cited by papers focused on Monoclonal and Polyclonal Antibodies Research (30 papers), Mosquito-borne diseases and control (24 papers) and Viral Infections and Vectors (19 papers). Syd Johnson collaborates with scholars based in United States, Sweden and Czechia. Syd Johnson's co-authors include Michael Diamond, Scott Koenig, Daved H. Fremont, Robert E. Bird, Sergey Gorlatov, Ezio Bonvini, Karl D. Hardman, Bennett Kaufman, James W. Jacobson and Marc Whitlow and has published in prestigious journals such as Nature, Science and Proceedings of the National Academy of Sciences.

In The Last Decade

Syd Johnson

80 papers receiving 8.4k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Single-Chain Antigen-Binding Proteins

1988 1.2k citations Robert E. Bird, Syd Johnson et al. profile →
Development of a Humanized Monoclonal Antibody (MEDI‐493) with Potent In Vitro and In Vivo Activity against Respiratory Syncytial Virus

1997 513 citations Syd Johnson, Cynthia N. Oliver et al. The Journal of Infectious Diseases profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Syd Johnson United States	46	2.8k	2.8k	2.7k	2.4k	2.0k	80	8.8k
Daved H. Fremont United States	75	7.2k 2.6×	1.5k 0.6×	6.1k 2.3×	3.6k 1.5×	6.9k 3.5×	218	17.7k
Scott Koenig United States	55	4.0k 1.4×	1.8k 0.7×	639 0.2×	2.8k 1.2×	5.9k 3.0×	102	13.6k
Britta Wahrén Sweden	56	3.3k 1.2×	1.5k 0.6×	467 0.2×	3.1k 1.3×	4.5k 2.3×	491	13.7k
Benjamin J. Doranz United States	48	3.5k 1.3×	1.0k 0.4×	2.0k 0.7×	2.0k 0.8×	4.1k 2.1×	104	9.2k
Anne S. De Groot United States	41	1.0k 0.4×	1.9k 0.7×	476 0.2×	3.4k 1.4×	2.8k 1.4×	231	6.3k
Quentin J. Sattentau United Kingdom	65	4.5k 1.6×	2.2k 0.8×	753 0.3×	3.7k 1.5×	6.9k 3.5×	171	14.7k
Scott Southwood United States	64	1.0k 0.4×	2.7k 1.0×	692 0.3×	5.5k 2.3×	9.4k 4.7×	116	13.3k
Sandra J. van Vliet Netherlands	45	1.5k 0.5×	1.0k 0.4×	524 0.2×	4.3k 1.8×	7.8k 3.9×	117	11.9k
Paul Pumpens Latvia	36	2.1k 0.8×	747 0.3×	470 0.2×	2.2k 0.9×	1.7k 0.9×	81	7.3k
Peter Pushko United States	33	3.3k 1.2×	516 0.2×	889 0.3×	2.1k 0.9×	1.7k 0.8×	65	8.0k

Countries citing papers authored by Syd Johnson

Since Specialization

Citations

This map shows the geographic impact of Syd Johnson's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Syd Johnson with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Syd Johnson more than expected).

Fields of papers citing papers by Syd Johnson

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Syd Johnson. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Syd Johnson. The network helps show where Syd Johnson may publish in the future.

Co-authorship network of co-authors of Syd Johnson

This figure shows the co-authorship network connecting the top 25 collaborators of Syd Johnson. A scholar is included among the top collaborators of Syd Johnson based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Syd Johnson. Syd Johnson is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Fox, Julie M., Vicky Roy, Bronwyn M. Gunn, et al.. (2019). Optimal therapeutic activity of monoclonal antibodies against chikungunya virus requires Fc-FcγR interaction on monocytes. Science Immunology. 4(32). 58 indexed citations

Liu, Liqin, Chia‐Ying K. Lam, Yinhua Yang, et al.. (2016). MGD011, A CD19 x CD3 Dual-Affinity Retargeting Bi-specific Molecule Incorporating Extended Circulating Half-life for the Treatment of B-Cell Malignancies. Clinical Cancer Research. 23(6). 1506–1518. 59 indexed citations

Sloan, Derek D., Chia‐Ying K. Lam, Alivelu Irrinki, et al.. (2015). Targeting HIV Reservoir in Infected CD4 T Cells by Dual-Affinity Re-targeting Molecules (DARTs) that Bind HIV Envelope and Recruit Cytotoxic T Cells. PLoS Pathogens. 11(11). e1005233–e1005233. 81 indexed citations

Purtha, Whitney E., Thomas F. Tedder, Syd Johnson, Deepta Bhattacharya, & Michael Diamond. (2011). Memory B cells, but not long-lived plasma cells, possess antigen specificities for viral escape mutants. The Journal of Experimental Medicine. 208(13). 2599–2606. 172 indexed citations

Nordstrom, Jeffrey L., Sergey Gorlatov, Wenjun Zhang, et al.. (2011). Anti-tumor activity and toxicokinetics analysis of MGAH22, an anti-HER2 monoclonal antibody with enhanced Fcγ receptor binding properties. Breast Cancer Research. 13(6). R123–R123. 183 indexed citations

Lai, Huafang, Michael J. Engle, Anja Fuchs, et al.. (2010). Monoclonal antibody produced in plants efficiently treats West Nile virus infection in mice. Proceedings of the National Academy of Sciences. 107(6). 2419–2424. 82 indexed citations

Verı́, Maria-Concetta, Stephen Burke, Ling Huang, et al.. (2010). Therapeutic control of B cell activation via recruitment of Fcγ receptor IIb (CD32B) inhibitory function with a novel bispecific antibody scaffold. Arthritis & Rheumatism. 62(7). 1933–1943. 59 indexed citations

Mehlhop, Erin, Steevenson Nelson, Sergey Gorlatov, et al.. (2009). Complement Protein C1q Reduces the Stoichiometric Threshold for Antibody-Mediated Neutralization of West Nile Virus. Cell Host & Microbe. 6(4). 381–391. 88 indexed citations

Morrey, John D., Venkatraman Siddharthan, Hong Wang, et al.. (2008). West Nile virus–induced acute flaccid paralysis is prevented by monoclonal antibody treatment when administered after infection of spinal cord neurons. Journal of NeuroVirology. 14(2). 152–163. 36 indexed citations

10.

Stavenhagen, Jeffrey B., Sergey Gorlatov, Nadine Tuaillon, et al.. (2007). Fc Optimization of Therapeutic Antibodies Enhances Their Ability to Kill Tumor Cells In vitro and Controls Tumor Expansion In vivo via Low-Affinity Activating Fcγ Receptors. Cancer Research. 67(18). 8882–8890. 211 indexed citations

11.

Mehlhop, Erin, Camilo Ansarah-Sobrinho, Syd Johnson, et al.. (2007). Complement Protein C1q Inhibits Antibody-Dependent Enhancement of Flavivirus Infection in an IgG Subclass-Specific Manner. Cell Host & Microbe. 2(6). 417–426. 109 indexed citations

12.

Morrey, John D., Venkatraman Siddharthan, Aaron L. Olsen, et al.. (2006). Humanized Monoclonal Antibody against West Nile Virus Envelope Protein Administered after Neuronal Infection Protects against Lethal Encephalitis in Hamsters. The Journal of Infectious Diseases. 194(9). 1300–1308. 77 indexed citations

13.

Mayall, F. & Syd Johnson. (2006). Immunoflow cytometry compared with PCR for the identification of clonality in FNAs of T‐cell‐rich B‐cell lymphomas. Cytopathology. 18(2). 117–119. 6 indexed citations

14.

Oliphant, Theodore, Michael J. Engle, Grant E. Nybakken, et al.. (2005). Development of a humanized monoclonal antibody with therapeutic potential against West Nile virus. Nature Medicine. 11(5). 522–530. 419 indexed citations

15.

Nybakken, Grant E., Theodore Oliphant, Syd Johnson, et al.. (2005). Structural basis of West Nile virus neutralization by a therapeutic antibody. Nature. 437(7059). 764–769. 283 indexed citations

16.

De, Barun K., Edwin W. Ades, Danny L. Jue, et al.. (2000). Purification and characterization of Streptococcus pneumoniae palmitoylated pneumococcal surface adhesin A expressed in Escherichia coli. Vaccine. 18(17). 1811–1821. 36 indexed citations

17.

De, Barun K., Jacquelyn S. Sampson, Edwin W. Ades, et al.. (1999). Baculovirus Expression, Purification and Evaluation of Recombinant Pneumococcal Surface Adhesin A of <i>Streptococcus pneumoniae</i>. Pathobiology. 67(3). 115–122. 3 indexed citations

18.

Rosenow, Carsten, Patricia Ryan, Jeffrey N. Weiser, et al.. (1997). Contribution of novel choline‐binding proteins to adherence, colonization and immunogenicity of Streptococcus pneumoniae. Molecular Microbiology. 25(5). 819–829. 361 indexed citations

19.

Johnson, Syd, Cynthia N. Oliver, Gregory A. Prince, et al.. (1997). Development of a Humanized Monoclonal Antibody (MEDI‐493) with Potent In Vitro and In Vivo Activity against Respiratory Syncytial Virus. The Journal of Infectious Diseases. 176(5). 1215–1224. 513 indexed citations breakdown →

20.

Colcher, David, Robert E. Bird, Mario Roselli, et al.. (1990). In Vivo Tumor Targeting of a Recombinant Single-Chain Antigen-Binding Protein. JNCI Journal of the National Cancer Institute. 82(14). 1191–1197. 250 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact